Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre …
R Carbonell, S Urgelés, A Rodríguez… - The Lancet Regional …, 2021 - thelancet.com
Background It is unclear whether the changes in critical care throughout the pandemic have
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …
Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
LB Laguna, P Marcos-Neira, IM de Lagrán Zurbano… - Clinical nutrition, 2022 - Elsevier
Background & aims Dysphagia can be a consequence of prolonged hospitalization in
intensive care units (ICUs) due to severe SARS-CoV-2 pneumonia. This study aims at …
intensive care units (ICUs) due to severe SARS-CoV-2 pneumonia. This study aims at …
[PDF][PDF] A comprehensive review on navigating the neurological landscape of COVID-19: insights into etiopathogenesis and clinical management
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has emerged as a global health crisis with significant …
coronavirus 2 (SARS-CoV-2) has emerged as a global health crisis with significant …
The use of complementary and traditional medicine for the treatment of patients with COVID-19: A systematic review
B Badanta, MA Garcia, AE Jimenez, G Lucchetti… - Explore, 2023 - Elsevier
Objective The aim of this study was to evaluate the use and effectiveness of non-
pharmacological therapies as part of the treatment of COVID-19 and its complications, either …
pharmacological therapies as part of the treatment of COVID-19 and its complications, either …
Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study
Á Estella, JLG Garmendia, C De La Fuente… - Medicina Intensiva …, 2022 - Elsevier
Objective The objective of the study is to identify the risk factors associated with mortality at
six weeks, especially by analyzing the role of antivirals and munomodulators. Design …
six weeks, especially by analyzing the role of antivirals and munomodulators. Design …
Recomendaciones para el manejo de los pacientes críticos con COVID-19 en las Unidades de Cuidados Intensivos
P Vidal-Cortés, ED Santos, EA Alonso, RA Menéndez… - Medicina intensiva, 2022 - Elsevier
La pandemia por COVID-19 ha provocado el ingreso de un elevado número de pacientes
en UCI, generalmente por insuficiencia respiratoria severa. Desde la aparición de los …
en UCI, generalmente por insuficiencia respiratoria severa. Desde la aparición de los …
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort …
G Moreno, R Carbonell, I Martin-Loeches… - Annals of Intensive …, 2021 - Springer
Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
P Vidal-Cortés, ED Santos, EA Alonso… - Medicina Intensiva …, 2022 - Elsevier
The COVID-19 pandemic has led to the admission of a high number of patients to the ICU,
generally due to severe respiratory failure. Since the appearance of the first cases of SARS …
generally due to severe respiratory failure. Since the appearance of the first cases of SARS …
[HTML][HTML] Effects of Oxiris® Therapy on Cytokine Elimination after a LPS Infusion—An Experimental Animal Study
The clinical effectiveness of Oxiris®, particularly in reducing cytokines, remains uncertain
due to the limited data provided. This study explored and analyzed the application value of …
due to the limited data provided. This study explored and analyzed the application value of …
Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic …
causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic …